Student Posters

(2-002) Retrospective Analysis of 400 Mg Intravenous Tocilizumab for Treatment of Patients Hospitalized with COVID-19

(2-003) Assessment of the Accuracy and Safety of Area Under the Curve Vancomycin Dosing Guidelines and Calculator in the Pediatric Population at a Large Community Hospital

(2-004) Acceptability and Feasibility of Digital Health Technologies for the Care of Older Adults During the COVID-19 Pandemic: A Systematic Review

(2-005) Treatment of Hepatitis C in an Indigent Population

(2-006) Introductory Pharmacy Practice Experience (IPPE) Students’ Changes in Knowledge, Attitudes, and Perceptions in Managing the Medical Care of Patients with Health Disparities

(2-007) Analysis of Fourth Year Student Pharmacists’ Perceptions of Health Disparities Before and After APPE Learning Experiences at Underserved Outpatient Clinical Practice Sites

(2-008) Optimizing Pain Management in the Community Pharmacy Setting Utilizing Preemptive Pharmacogenomic Screening of CYP2D6 and CYP2C9

(2-009) Effect of Blood Eosinophils on Corticosteroid Responsiveness During Acute Exacerbations of COPD

(2-010) Title: Pharmacist-led Motivational Interviewing Effects on Medication Adherence in Outpatient Clinic Settings: A Systematic Review

(2-011) Assessing Control of Asthma and Chronic Obstructive Pulmonary Disease (COPD) in a Charitable Pharmacy

(2-012) Beliefs Regarding Mindfulness-Based Stress Reduction for Treatment of Chronic Pain Among the U.S. General Public: A National Survey

(2-013) Evaluation of Vasopressin Utilization at a Central Alabama Community Hospital

(2-014) Evaluation of Stress Ulcer Prophylaxis in Hospitalized Geriatric Patients

(2-015) Comparison of Bamlanivimab/etesevimab and Casirivimab/imdevimab for the Treatment of High-Risk COVID-19 Patients

(2-016) Clinical Status and Time to Antiretroviral Initiation in Patients Screened HIV-1 Positive at a Regional Hospital in the Southeast

(2-017) Evaluation of Rapid Antiretroviral Therapy Initiation and Transitions of Care of Patients Newly Diagnosed with HIV-1 Infection During Hospitalization

(2-018) Retrospective Evaluation of Low-Dose Subcutaneous Tocilizumab for the Treatment of Patients Hospitalized with COVID-19

(2-019) Reduction of Paclitaxel Infusion Reactions at an Outpatient Adult Gynecologic/Oncology Infusion Clinic

(2-020) Students' Perceptions of the Effectiveness of Near-Peer Teachers in Pharmacy Education

(2-021) Two Year Evaluation of Podcasts as the Primary Teaching Method in a Pharmacy Post-Graduate Training Elective

(2-022) Best Practices for Promoting Scholarship in Pharmacy Practice

(2-023) Sedation Weaning in Patients with an Uncontrolled Psychiatric History

(2-024) Impact of a Meds-to-Beds Program on 30-Day Readmissions for CMS-Targeted Conditions

(2-025) Comparing the Effects of Heparin Infusion Maximum Dose Limits in Morbidly Obese Patients to Weight-based Dosing in Non-obese Patients

(2-026) Evaluation of Melatonin Use on Benzodiazepine and Opioid Requirements and Pain Scores in Critically Ill Pediatric Patients

(2-027) Female First and Senior Authorship in Critical Care Publishing

(2-028) Students’ Perceptions of the Role of Near-Peer Teachers in Pharmacy Education

(2-029) Assessing Adherence to Consensus Recommendations for Prescribing of Omega-3 Fatty Acids in Patients with Atherosclerotic Cardiovascular Disease

(2-030) Retrospective Analysis of Partial Fill Prescription Processing at a Veterans Affairs Medical Center (VAMC)

(2-031) Development of Novel Doxycycline Topical Formulations to Combat Methicillin Resistant Staphylococcus Aureus

(2-032) Evaluation of Antimicrobial Stewardship Practices from a Multi-disciplinary MICU Team at a Small, Non-teaching Hospital

(2-033) Assessment of Pharmacist Knowledge and Confidence in Providing Pediatric Vaccinations Before and After Educational Programing

(2-034) Deciphering the Reality Behind CBD Oil in a Pre-clinical Model of Alzheimer’s Disease

(2-035) Descriptive Review of the Formulation Conversion of Inhaled Corticosteroid/Long-Acting Beta-Agonist (ICS/LABA) Inhalers at a Veterans Affairs Medical Center

(2-036) Prepping for PrEP: Evaluating the Impact of an Educational In-service on PrEP Therapy

(2-037) Retrospective Review of a Pharmacist-Managed Transitions of Care Service at a Federally Qualified Health Center: Financial and Clinical Outcomes

(2-038) Evaluation of Pharmacist-led Medicare Annual Wellness Visits to Satisfy Quality Metrics and USPSTF Recommendations After Implementation of a Post-Visit Follow-Up Protocol

(2-039) Evaluation of Clinical Outcomes with Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) Therapy in a Predominantly Underserved Patient Population

(2-040) Evaluation of Provider Awareness and Understanding of Stroke Risk and Anticoagulation Therapy in Patients with Non-Valvular Atrial Fibrillation

(2-041) Effectiveness and Safety of Transitions from Parenteral Anticoagulation to Rivaroxaban or Apixaban for Venous Thromboembolism Treatment

(2-042) Lumacaftor Inhibits cAMP-Dependent Iodide Efflux Through Rescued F508del CFTR in a Bronchial Epithelial Cell Line

(2-043) Association of Opioid Utilization in the Medical Intensive Care Unit and Incidence of a New Opioid Prescription in Opioid Naive Patients

(2-044) Association of Opioid Use in the Medical Intensive Care Unit and the Prevalence of Opioid Prescribing at Discharge (OMICU)

(2-045) Assessing the Appropriateness of Heparin Infusions for the Treatment of Acute Venous Thromboembolism (VTE) at a Tertiary Medical Center

(2-046) Investigation of Clinically Relevant Metabolic Interactions Between Levodopa and Cannabinoids

(2-047) Assessment of Selective Serotonin Reuptake Inhibitor (SSRI) Prescribing Practices in the Geriatric Outpatient Population with Major Depressive Disorder at a Veterans Affairs (VA) Medical Center

(2-048) Evaluating the Safety of Bayesian Modeling versus Two-Level Trapezoidal Area Under the Curve (AUC)-based Dosing of Vancomycin When Used Concomitantly with Piperacillin-Tazobactam

(2-049) Impact of Pre-hospital Anticoagulant And/or Antiplatelet Therapy on Clinical Outcomes for Patients Hospitalized with COVID-19

(2-050) Incidence and Timing of Reactions in Patients Receiving Subcutaneous Daratumumab

(2-051) Assessing Albuterol Prescribing Patterns in Pediatric Patients with Asthma

(2-052) Impact of Elexacaftor/Tezacaftor/Ivacaftor on Cystic Fibrosis Associated Gastrointestinal Disease and Symptoms in Pediatric Patients: A Retrospective Analysis

(2-054) Observational Assessment of Predictors of Stool DNA Testing and Up-To-Date Screening of Colorectal Cancer

(2-055) Predictors of Exercise Engagement Among U.S. Residents Diagnosed with Myalgia

(2-056) Outcomes Associated with Methicillin-resistant Staphylococcus Aureus vs. Methicillin-susceptible S. Aureus Coinfections in Coronavirus Disease 2019

(2-057) Association of Social Stability with Illicit Drug Use

(2-058) Predictors of Receiving Drug Therapy, Counseling, or Both in U.S. Ambulatory-Care Patients Diagnosed with Attention-Deficit Disorder/Attention-Deficit Hyperactivity Disorder (ADD/ADHD)

(2-059) Development of an in Vitro Assay for Detection of Nephrotoxicity of Commonly Used Drugs

(2-060) Provider Decision-Making in Response to an Automated, Electronic Antibiotic Time-Out Alert After 48 Hours of Antibiotic Therapy

(2-061) Risk Factors Associated with Prescription Sedative, Stimulant, and Tranquilizer Drug Abuse with a Focus on Factors Available to a Dispensing Pharmacist

(2-062) Pharmacist Impact on Diabetic Ketoacidosis Outcomes in the Emergency Department at Tucson Medical Center

(2-063) Evaluation of Student-Led Beta-Lactam Allergy Delabeling at Northwest Medical Center

(2-064) Pharmacist Led Interventions in Hepatitis C Management

(2-065) Surveying Patients and Pharmacists to Assess the Knowledge of Medication-related Risks in Celiac Disease

(2-066) Applying the Health Belief Model to the General Public’s Perceptions of Community-Based Dementia Resources

(2-067) Clinical Pharmacist Impact on Patient Pain Scoring over a Four-month Period in a Primary Ambulatory Care Setting

(2-068) Influenza Vaccination Perceptions Among Pharmacy Students During the COVID-19 Pandemic

(2-069) An Assessment of Vancomycin Target Attainment After Implementation of an Area Under the Concentration-Time Curve Dosing Strategy Using Bayesian Modeling

(2-070) Measuring the Impact of an Additional Healthcare Component to a Poverty Simulation on the Attitudes of Interprofessional Healthcare Students

(2-071) Evaluating the Impact of Educational Interventions on Prescribing Practices in Pediatric Urinary Tract Infections Between a Non-Academic and an Academic Children’s Hospital

(2-072) Addressing Health Disparities in Antimicrobial Prescribing for Urinary Tract Infections in a Pediatric Emergency Department

(2-073) Small Cell Lung Carcinoma and Synchronous Rectal Adenocarcinoma and Jejunal Gastrointestinal Stromal Tumor Present in a Patient with History of Laryngeal Squamous Cell Carcinoma

(2-074) Effects of Glucagon-Like-Peptide-1 Receptor Agonists (GLP-RA) on Cardiovascular Outcomes in Patients with Chronic Kidney Disease (CKD): A Systematic Review and Meta-Analysis

(2-075) Pharmacogenomics Interactions of Drugs Used for Alzheimer’s Disease

(2-076) Substance Use Education in U.S. Pharmacy Schools: Fentanyl Test Strips and Other Harm Reduction Strategies

(2-077) Pro Re Nata (PRN) Usage of Antipsychotic Medications in an Acute Care Setting

(2-078) Surrogate Endpoints Used in Clinical Trials of Esophageal Cancer Therapies Within the United States: A Systematic Literature Review

(2-079) Appropriateness of Direct Oral Anticoagulants Dosing in Patients with Nonvalvular Atrial Fibrillation Managed by an Interdisciplinary Team

(2-081) Oral Step down Compared to Extended Intravenous Antibiotics Therapy in Patients with Gram-negative Bacteremia: A Retrospective Cohort Study

(2-082) Mental Health in Dialysis Nurses During COVID-19

(2-083) Evaluation of the in-vitro Antibacterial Activity of SPR206 Against Multidrug- resistant Acinetobacter Baumannii

(2-084) Investigating Hemoglobin A1C Change in Patients Who Are Referred to an Ambulatory Care Pharmacist in the Outpatient Setting

(2-085) Ivabradine Therapy Appropriateness and Its Implications for Heart Failure Patients

(2-086) Evaluation of Sodium Zirconium Cyclosilicate versus Sodium Polystyrene Sulfonate Monotherapy for Acute Hyperkalemia

(2-087) Development of an in Vitro Co-culture Model to Study the Interactions Between Acute Myeloid Leukemia Cells and Blood Brain Barrier Cells

(2-088) Relationship Between Lipid Formulation and Central Line Associated Bloodstream Infections in Patients Requiring Parenteral Nutrition

(2-089) Comparing Single to Multiple Block Scheduling of the Advanced Pharmacy Practice Experiences (APPE) at Desert Valley Hospital (DVH) from 2021 to 2022

(2-090) Racial Disparities in Management and Treatment of Cystitis at a Large Academic Emergency Department and Urgent Care Settings

(2-091) The Antipsychotic Chlorpromazine (Thorazine) for Treatment of Pain

(2-092) The Influence of hsa-miR-370-3p and CYP2D6 on Steady-state Concentration of Paroxetine in Patients with Depressive Disorder

(2-093) Acute Effects of Enhanced External Counterpulsation (EECP) on Cardiac Output

(2-094) Changes in Perceived Stress of Pharmacy Students Pre- and Mid-COVID-19 Pandemic

(2-095) Cost-Utility Analysis of Academic Detailing Outreach on Naloxone Prescribing for Patients at Risk of Opioid-Related Overdose

(2-096) Trends in Concomitant Opioid and Benzodiazepine Exposures Reported to California Poison Control System Following CDC Release of 2016 Opioid Guidelines

(2-097) Views and Perceptions of Medical Representatives and Physicians About the Role of Medical Representatives and Pharmaceutics Advertisement in Saudi Arabia – a Pilot Study

(2-098) Comparison of Healthcare Expenditures Among People with Diabetes with and Without Mental Health Disorders

(2-099) Pediatric Cystic Fibrosis Pharmacist Clinic Visit Outcome Analysis: A Four-Year Follow-Up

(2-100) Impact of Elexacaftor/Tezacaftor/Ivacaftor on Pulmonary Function Tests in Adult and Pediatric Cystic Fibrosis Patients

(2-101) Assessment of Healthcare Providers’ Knowledge and Attitudes Towards Opioid Misuse Before and After a Hybrid, Inter-professional Opioid Overdose Workshop

(2-102) Value of Expanding Intern Pharmacists’ Clinical Responsibilities in an Academic Medical Center

(2-103) Outcome of Enoxaparin Bridging in Left Ventricular Assist Devices in an Ambulatory Care Setting

(2-104) Assessing the Current Landscape of Direct-to-Consumer Advertising: An Analysis of Prescription Product Advertisements Found in Consumer Magazines

(7-180) A Multi-State Review of Board of Pharmacy Consulting Rules and Regulations

(2-106) Industry Pharmacist Job Satisfaction Analysis

(2-107) Pharmacy Implication of FDA’s Diversity Plan for Clinical Trials

(2-108) Alteplase versus Tenecteplase for Acute Ischemic Stroke: A Retrospective Cohort Analysis

(2-109) The Impact of Online Learning on Academic Performance and Confidence in Pharmacy Student Learning Outcomes

(2-110) The Impact of Clinical Equations on Carboplatin Dosing: A Systematic Review to Determine Appropriate Dosing of Carboplatin in Adult Cancer Patients

(2-111) Implementation of Tenecteplase for Acute Ischemic Stroke (AIS) at a Comprehensive Stroke Center (CSC) Community Hospital

(2-112) Emergency Preparedness: Food Insecurity During COVID-19 Pandemic

(2-113) Rare Case of Varicella Zoster Meningitis

(2-114) B Cells from Individuals with Trisomy 21 Have Altered Activation Compared to Disomic Individuals

(2-115) Changes in Self Perceived Student Stress in P1, P2, and P3 Pharmacy Students at Regis University

(2-116) West Nile Virus Meningoencephalitis

(2-117) Factors Associated with Unscheduled Return Visits to the Emergency Department: A Case-control Study

(2-118) Characteristics of Patients Treated with Romosozumab as Compared to Parathyroid Hormone Analogs

(2-119) Guiding Central Inventory Optimization in an Inpatient Community Hospital Pharmacy

(2-120) Post-intubation Sedation Practices Within Emergency Departments Across a Large Pediatric Healthcare Organization

(2-121) Assessment of Analgesic Pain Control in Living Donor Nephrectomy Patients After Implementation of an Opioid Stewardship Initiative

(2-122) Impact of a Pharmacy Intern in a Heart Failure Clinic

(2-123) Evaluation of the Effectiveness of a Pharmacist-Led Diabetes Management Protocol on A1c Reduction in Patients with Uncontrolled Diabetes

(2-124) Retrospective Evaluation of the Effectiveness of a Clinical Pharmacy Driven Quality Improvement Initiative Targeting Blood Pressure Control

(2-125) Evaluation of an Institutional Anticoagulant Thromboprophylaxis Protocol for Hospitalized Patients Infected with the COVID-19 Delta or Omicron Variants

(2-126) Patient Health Outcomes Related to Pharmacy Intervention in Medication Reconciliation

(2-127) Hospital-compounded Dextrose Injection 50% Stored in Polypropylene Syringes Maintains Potency for at Least 90 Days in a Stability Sensing Assay

(2-128) Evaluation of Short Acting Intramuscular Olanzapine Use in the Emergency Department at an Academic Medical Center

(2-129) Evaluation of an Argatroban Protocol for Confirmed/Suspected Heparin Induced Thrombocytopenia (HIT)

(2-130) Dosing and Operational Evaluation of Human Prothrombin Complex in a Multi-Site Hospital System

(2-131) Adherence to Atypical Antipsychotic Monitoring Recommendations in a Primary Care Clinic for Children and Youth with Special Health Care Needs (CYSHCN)

(2-132) Evaluation of Home Test Kits to Streamline Healthcare Utilization for Urinary Tract Infections (UTI)

(2-133) Use of Sodium Hypochlorite and Hydrogen Peroxide to Decontaminate Compound Areas

(2-134) Proposal to Remove Rifaximin 550mg Tablets from Formulary in Favor of 200mg Tablets at Hartford Healthcare

(2-135) Potential Risk of Direct Oral Anticoagulant Use in Patients with Inflammatory Bowel Disease

(2-136) Characteristics of a Safety Net Population with Uncontrolled Hypertension: A Cross-Sectional Analysis

(2-137) Prescribing Patterns’ Alignment with Congestive Heart Failure Recommendations Among Patients Who Received Transitions of Care Services from a Health Systems Integrated Community Pharmacy

(2-138) Bromocriptine for Central Hyperthermia After Acute Brain Injury: A Retrospective Cohort Study

(2-139) Assessing Appropriate Intravenous Levetiracetam Use in Two Community Hospitals

(2-140) Evaluation of the Impact of Home Based Primary Care (HBPC) on COVID-19 Vaccination Rates

(2-141) Where to Start with Medication Safety? A Review of the Institute for Safe Medication Practice’s Resource Library

(2-142) Assessing Covid-19 Vaccine Waste in a Healthcare System

(2-143) Treatment of Babesiosis in a Patient with Complex Cardiovascular History and Chronically Elevated QTc: Azithromycin Plus Atovaquone

(2-144) The Impact of Berberine Alone vs. Control on Lipoprotein Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis

(2-145) Impact of Berberine-Containing Products versus Active Drug or Dietary Therapy on Lipoprotein Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis

(2-146) Comparing the Outcomes of Transitions of Care Services Among Hispanics with and Without Limited-English Proficiency Through a Health System’s Integrated Community Pharmacy

(2-147) Supporting Underrepresented and Marginalized Students in Predominantly White Institutions Through Mentorship Programs

(2-148) Identifying the Ideal Pediatric Residency Candidate: A Residency Program Director's Perspective

(2-149) Evaluation of Hepatitis B Vaccine in Liver Cirrhosis Patients

(2-150) Evaluation of Pharmacist Interventions to Initiate Continuous Blood Glucose Monitoring in Patients at a Federally Qualified Health Center

(2-151) Evaluation of Guideline-Directed International Normalized Ratio Goal for Outpatient Anticoagulation Management

(2-152) HBCU vs Non-HBCU Pharmacy Residency Match Rate

(2-153) Impact of a Clinical Pharmacist on Medication Adherence in Patients with Bipolar Disorder

(2-154) Impact of a Clinical Pharmacist on Immunosuppressive Medication Adherence in Kidney Transplant Patients

(2-155) Comparison of Acute Psychiatric Inpatient Treatment Strategies of Patients with Bipolar Disorders with Length of Stay and Other Parameters

(2-156) An Analysis of Antipsychotic Drug Therapy in Patients with Schizoaffective Disorder

(2-157) Coronavirus Disease (COVID-19) Vaccine Schedule Compliance: A Retrospective Analysis in a Population of Medically Underserved and Underinsured Adults in Northwest Florida

(2-158) An Evaluation of Pharmacist Burnout During COVID-19

(2-160) Impact of Telehealth Services for the Management of Type I and II Diabetes Mellitus

(2-161) Monitoring Outpatients on Amiodarone Therapy at the James A. Haley Veterans’ Hospital (JAHVH)

(2-162) Time to Goal: Evaluation of Heparin Infusion Protocols at a Newly Opened Acute Care Hospital

(2-163) Medication Use Evaluation of Fosphenytoin Therapeutic Drug Monitoring in the Intensive Care Unit at Sarasota Memorial Health Care System (SMHCS)

(2-164) Comparing Sarasota Memorial Health Care System (SMHCS) Postoperative Opioid Prescribing Practices at Hospital Discharge to National Recommendations

(2-165) Comparison of the Differential Pharmacokinetic Parameters for Ensuring Safe and Effective Cannabis Therapeutic Use in Epilepsy

(2-166) Evaluation of Efficacy and Safety of Tirzepatide for the Treatment of Type 2 Diabetes

(2-167) Retrospective Medication Use Evaluation of Hydromorphone 2mg Intravenous Push Utilization in Hospitalized Adult Patients at a Community Hospital

(2-168) Initiation of Dofetilide Following Rapid Transition from Amiodarone

(2-169) Results of a Pilot Study for Pharmacy Discharge Review in Neurosurgical Patients: A Quality-Safety Initiative

(2-170) Clinical Development of Dupilumab for Moderate to Severe Atopic Dermatitis: A Literature Review

(2-171) Evaluating the Effect of Intravenous Meloxicam on Postoperative Opioid Use in Orthopedic Surgeries

(2-172) Evaluation of Intravenous Minocycline Restriction Criteria in the Inpatient Setting at a Community-Based Healthcare System

(2-173) Evaluation of Glucagon Use in Hospitalized Adult Patients

(2-174) Prevalence of Urate-Lowering Therapy Use Among Adults with Gout and the Relationship Between Gout Treatment Status and Associated Comorbidities

(2-175) The Use of Beers List Medication in Patients 40-64 Years Old Compared to Patients 65 and Older

(2-176) Rare Multisystem Inflammatory Syndrome in Adults (MIS-A): A Case Report

(2-177) Primary Data Review and Supplemental Aid for Clinicians Using Antineoplastic Agents in Patients Requiring Dialysis

(2-178) Factor VII, VIII and IX Product Utilization in a Multicenter Community Health Care System

(2-179) Impact of an Outpatient Palliative Care Clinic on Emergency Department Visits/Hospitalizations for Established Palliative Care Patients

(2-180) Prevalence of Psychotropic Drug Use in Children Aged 6-17: NHANES 2013-2018

(2-181) Utilization of the Cytochrome P450 Drug-Drug Interaction Between Olanzapine and Fluvoxamine to Improve Symptoms in Schizophrenia: A Case Report

(2-182) Potential Benefit of Naltrexone in a Patient with Autistic Disorder and Borderline Personality Disorder Exhibiting Self Injurious Behaviors

(2-183) Medication Use Evaluation of SGLT2 Inhibitors in a Community Healthcare System

(2-184) Evaluating the Prevalence of Inappropriate Correctional Insulin Prescribing Practices at Discharge Across a Healthcare System

(2-185) Optimization of Medication Request Workflow to Reduce Medication Delays

(2-186) Controlling Blood Pressure During a Pandemic: The Impact of Telepharmacy for Primary Care Patients

(2-187) An Evaluation of Pharmacist Interventions Within a Primary Care Clinic on 30 and 90 Day Heart Failure Readmission Rates

(2-188) Evaluating the Role of Factor XI(a) Inhibition in Preventing Venous Thromboembolisms

(2-189) Analysis of the Use of Pantoprazole Dosed up to Four Times Daily in Patients with Peptic Ulcer Disease

(2-190) Chlorthalidone versus Hydrochlorothiazide: A Comparison of Efficacy and Safety Outcomes in the Existing Literature

(2-191) Implementation of a Pharmacist-Led Long-Acting Injectable Antiretroviral Therapy Service at a Hospital-Based Infectious Disease Clinic

(2-192) Assessing the Impact of Candida Auris on a Community Hospital

(2-193) Chronic Medication Use Among People with HIV Compared to the General Population

(2-194) Clinical and Economic Impact of Blood Culture Contamination at a Multi-Center Health System

(2-195) Eradication of Resistant and Non-resistant H. Pylori Infection with Vonoprazan: A Review

(2-196) Effect of Radiation Therapy on CD4 Count in HIV Patients with Undetectable Viral Load

(2-197) Assessing the Impact of Chlorpromazine Dose Equivalents on Acute Agitation Episodes in Patients with Schizophrenia and Schizoaffective Disorder

(2-198) Management of Cyclic Catatonia in a Bipolar Patient Using Lithium

(2-199) Assessment of Provider Knowledge and Therapeutic Approaches for Reducing Stroke Risk in Patients with Nonvalvular Atrial Fibrillation

(2-200) Financial Reimbursement of a Student Pharmacist and Pharmacy Resident-Run Chronic Care Management Program in a Privately-Owned Family Medicine Clinic

(2-201) Evaluation of Daratumumab and Hyaluronidase (Darzalex Faspro) Administration-related Reactions at a Community Cancer Center

(2-202) Evaluating Pharmacy Students’ Perceptions on the Need for Post-Graduate Training Pre- and Post-COVID-19 Pandemic

(2-203) Combatting Misinformation and Vaccine Hesitancy in Underrepresented South Florida Populations

(2-204) Optimizing an Inpatient Hospital’s Pharmacy Technician Operation to Improve Medication Delivery and Reduce Delays in Patient Care

(2-205) Retrospective Medication Use Evaluation of Intravenous Albumin Administration in Hospitalized Adult Patients at a Community Hospital

(2-206) Lenacapavir: An Investigational Long-Acting Capsid Inhibitor for the Treatment of Human Immunodeficiency Virus 1 Infection (HIV-1)

(2-207) High-Evidence Actionable Pharmacogenomics in a Multispecialty, Tertiary Care Clinic

(2-208) The Prescribing Patterns of Urinary Tract Infection Management in Adult Patients at a Free Student-Run Free Clinic: A Retrospective Study

(2-209) Dose Impact on Hypoglycemia After Administration of IV Regular Insulin for the Treatment of Hyperkalemia

(2-210) Using Thiamine Supplementation in Lactic Acidosis Where Blood Pressure Is Already Optimized: A Retrospective Analysis

(2-211) Medication Use Evaluation of Injectable Promethazine in the Emergency Department Setting at an Academic Medical Center

(2-212) Chlorpromazine Injection in the Emergency Department

(2-213) Defining Key Pharmacist and Technician Roles in Response to a Hospital Downtime or Cyberattack

(2-214) Assessment and Management of Extended Spectrum Beta-Lactamase Urinary Tract Infections in Patients from the Emergency Care Center or Urgent Care Center

(2-215) User Experience Evaluation of the Current Format for Clinical Pharmacogenomics Consult Documentation

(2-216) Efficacy of a Revised Tool on Identifying Patients at Risk for Opioid-induced over Sedation and Respiratory Depression

(2-217) Effect of a Pharmacist Driven Pediatric Heparin Protocol on Time to Therapeutic Levels in a Pediatric Intensive Care Unit

(2-218) Acute Respiratory Failure – Is It COVID-19 or Cannabis?

(3-088) A Continuation of Antibiotic Stewardship Intervention in the Optimization of Duration of Therapy for Community Acquired Pneumonia

(2-220) Evaluation of CHA2DS2-VASc in Atrial Fibrillation Patients Receiving Anticoagulation in the Outpatient Setting

(2-221) Evaluation of Anticoagulation Administration Post Cardiac Ablation in Patients with Atrial Fibrillation

(2-222) Comparison of Heparin Nomograms on Time to Therapeutic Partial Thromboplastin Time (PTT)

(2-223) Association of Genetic Polymorphisms and Loop Diuretic Interactions with Survival in Patients with Heart Failure

(2-224) Determining the Effect of Bivalirudin on INR Levels in Hospitalized Patients Receiving Warfarin Bridging Therapy

(2-225) Driving Sustainable Clinical Practice Change to Optimize Outcomes for Patients with Hypercholesterolemia - Scale Up: Integration of the PA Checklist in Clinical Practice

(2-226) Establishing Internal Medicine Pharmacist Services by Resource Reallocation and Hospitalist Collaboration

(2-227) Effectiveness of Inhaled Epoprostenol as Compared to Inhaled Nitric Oxide in Acute Respiratory Distress Syndrome

(2-228) Venous Thromboembolism Prophylaxis Dosing and Incidence of Thrombosis in Trauma Patients at a Level II Trauma Center

(2-229) Monitoring Temperature in Targeted Temperature Management in an Anatomically-Limited Patient

(2-230) Improving Analgesia with Methadone After Large Burn Injury

(2-231) Concomitant Use of Levothyroxine and Interacting Medications in US Ambulatory Care Visits

(2-232) Efficacy of 10% Dextrose Compared to 50% Dextrose for Treatment of Acute Hypoglycemia

(2-233) Evaluating Appropriate Use of Albumin 25% Intravenous Solution at a Community Hospital

(2-234) Evaluating Antihypertensive Medication Usage in Patients with Apparent Treatment Resistant Hypertension (aTRH) Within the State of Florida Using Electronic Health Record (EHR) - Based Data

(2-235) Drug Use Evaluation of Micafungin

(2-236) Evaluation of Antibiotic Utilization and Opportunities for Improved Prescribing in a VA Community-Based Outpatient Clinic

(2-237) Use of Psychotropic Medications with Pharmacogenomics Implications at a Multi-State Pediatric Health System

(2-238) Evaluation of a Weight-Based Heparin Drip Protocol for Patients with Higher Risk of Intracerebral Bleed Due to an Acute Ischemic Stroke

(2-239) Boosting Tacrolimus Trough Concentrations with a Cytochrome-P450 3A4 Inhibitor

(2-240) Chloroprocaine for Epidural Labor Analgesia in a Patient with Lidocaine Allergy: A Case Report

(2-241) Culture Negative Tropheryma Whipplei Endocarditis: A Case Report

(2-242) Prevention of Pneumonia in Post-ROSC Patients Using Broad-Spectrum Antibiotics

(2-243) Impact of a Pharmacist-Led Transitions of Care Protocol Implemented in a Geriatric Outpatient Clinic

(2-244) Effects of a System Implemented Anticoagulation Management Protocol for Impella CP Patients

(2-245) Functionality Assessment of Gene-Disease Pharmacogenomic Clinical Decision Support (PGx-CDS) Implementation in a Clinical Practice Setting

(2-246) Ascorbic Acid’s Use in Reducing the Incidence of Methemoglobinemia in Patients Treated with Inhaled Nitric Oxide in ARDS/COVID19

(2-247) Optimizing Naloxone Education and Distribution for Veterans with an Opioid Use Disorder Diagnosis

(2-248) Mental Health Trends in Transgender Adults Receiving Gender-Affirming Hormone Therapy at a Student-Run Free Clinic

(2-249) Protein C Replacement Therapy in Adults with Meningococcemia and Purpura Fulminans

(2-250) Evaluation of Blood Glucose After Administration of Intravenous Insulin for the Treatment of Hyperkalemia

(2-251) Medication Use Evaluation of Iron Sucrose for Iron-Deficiency Anemia: A Multicenter, Retrospective Analysis

(2-252) Retrospective Analysis of Sodium Zirconium Cyclosilicate Use for Hyperkalemia in a Community Hospital

(2-253) Impact of Avoiding Use of a Pain Scale Within PRN Comments on Pain Medication Orders on a Patient’s Overall Opioid Use

(2-254) Analysis of Student Outcomes from an Interprofessional Education Transitions of Care Simulation

(2-255) Does Utilizing Low Fidelity Simulations in a Clinical Pharmacokinetics and Pharmacodynamics Course Enhance Student Performance on Similar Skills During APPE Rotations?

(2-256) Comparing Combined Oral Contraceptives: Norethindrone/ Ethinyl Estradiol and Drospirenone/ Ethinyl Estradiol

(2-257) Evaluation of Agitation or Delirium-Induced Antipsychotic Initiation from ICU to Hospital Discharge in a Community Teaching Hospital

(2-258) Assessing Outcomes of Patients Concomitantly on Cobicistat or Ritonavir for HIV Antiretroviral Therapy and a Long Acting Beta2-Agonist

(2-259) Characterization of Patients with COPD and Heart Failure Who Enroll in a Bedside Medication Delivery Service

(2-260) Use of Intrathecal Milrinone for Refractory Cerebral Vasospasm in a Pediatric Patient with a Traumatic Subarachnoid Hemorrhage

(2-261) Evaluating Defibrotide Use for Prevention and Treatment of Veno-Occlusive Disease in High-Risk Pediatric Bone Marrow Transplant Patients

(2-262) Evaluating the Implementation of an Electronic-Based Diabetic Ketoacidosis Protocol in the Emergency Department

(2-263) Mid-Twentieth to Twenty-first Century Public Health Emergencies as a Catalyst for the Evolution of the Practice of Pharmacy

(2-264) The Role of Pharmacists Within an AIDS Service Organization in JYNNEOS Vaccine and TPOXX Acquirement, Inventory, and Administration During the Monkeypox Public Health Outbreak

(2-265) Copper Deficiency in Hospitalized Patients with Liver Disease

(2-266) Evaluation of Risk Factors for Vitamin B6 Deficiency in Adult Hospitalized Patients

(2-267) Caplacizumab Use Postpartum to Treat Immune-Mediated Thrombotic Thrombocytopenic Purpura

(2-268) Comparison of Two Cohorts of an International Vaccination Delivery Certificate Training Program

(2-269) Retrospective Review of Clinical Outcomes After Intravenous to Oral Conversion

(2-270) Impact of a US-Based Telemedicine Service on Patient Clinical Outcomes in Nigeria

(2-271) Patient and Healthcare Volunteer Experiences During a Multidisciplinary Virtual Medical and Surgical Mission Trip

(2-272) Evaluation of Basiliximab for Induction in Liver Transplant Patients

(2-273) Recently Reported Side Effects and Drug Interactions of Antivirals

(2-274) Pharmacists’ Attitudes Towards Firearm Violence on Workplace Safety

(2-275) Establishing an Interprofessional and Collaborative Continuous Glucose Monitoring Service in a Family Medicine Graduate Medical Education Clinic

(2-276) Risk-Benefit Analysis of a Patient with Ehlers-Danlos Syndrome Presenting with Hemostatic Abnormalities

(2-277) Evaluating the Impact of Early Switch from Intravenous to Oral Antibiotics in Established Antimicrobial Stewardship Programs

(2-278) Role of Anti-PD-1/PD-L1 Therapy in Infectious Disease

(2-279) Voxelotor Effects on Hemoglobin Levels in Children with Sickle Cell Disease

(2-280) Acetaminophen Toxicity: Treatment with Acetylcystine and Fomepizole

(2-281) Efficacy and Safety of Therapeutic Drug Monitoring in Pediatrics with Inflammatory Bowel Disease Using Anti-Tumor Necrosis Factor Antibodies

(2-282) Evaluating Hyponatremia in Patients Receiving Sodium Glucose Co-Transporter 2 Inhibitors (SGLT-2i)

(2-283) Safety and Efficacy of Brexanolone as a Novel Treatment Option for Postpartum Depression: A Systematic Review

(2-284) In vitro High Throughput Screening for the Inhibitory Effect of Phytochemicals Against SARS-CoV-2 Proteolytic and Deubiquitinase Activities

(2-285) Traumatic Induced Intracranial Hemorrhage Stroke Management in 32 Year Old African American Male

(2-286) Recently Reported Side Effects and Drug Interactions of Antifungal Medications

(2-287) The Electronic Health Record Objective Structured Clinical Examination Station

(2-288) Assessment of Ghanaian Pharmacists and Residents’ Awareness of Expedited Partner Therapy and Their Views Toward It Receiving Governmental Support

(2-289) The Impact of Patient Interactions via Telehealth with Migrant and Seasonal Agricultural Workers on Student Pharmacist Confidence and Avoidance Behavior

(2-290) Consumers’ Reasons for Purchasing Over-the-counter Products Marketed for Cardiovascular Health

(2-291) The Impact of Patient Interactions with Limited English Proficient Patients via Telehealth on Student Pharmacist Confidence in Using Skilled Interpreters

(2-292) Student Pharmacists Increase Migrant and Seasonal Agricultural Workers’ Access to Comprehensive Medication Information Using Telehealth

(2-293) Treatment with MDL 72527 Suppressed Optic Nerve Inflammation in an Experimental Model of Multiple Sclerosis

(2-294) Effect of Prescribing GLP-1 Agonists on Weight and Insulin Dose in Patients Maintained on Insulin Therapy

(2-295) Milrinone Compared with Dobutamine on Impella Support Duration in Patients with Cardiogenic Shock

(2-296) Mapping Georgia Community Pharmacies and Clinics: An Evaluation of Diabetes Mellitus Outcomes and Access to Care

(2-297) Evaluation of the Utilization and Prescribing Practices of Tolvaptan at a Level 1 Trauma Center in Southeast Georgia

(2-298) Tixagevimab-cilgavimab: Access, Equity, and Outcomes at an Academic Medical Center

(2-299) Gastric Bypass-Related Hyperammonemia

(2-300) Evaluating Synagis Usage in an Outpatient Setting

(2-301) Evaluation of Combination Opioid and Benzodiazepine Therapy in Spinal Cord Injury Patients Treated with a Benzodiazepine for Spasticity Management at a Veterans Affairs Medical Center

(2-302) Evaluation of a Chronic Care Management Pilot Project and Revenue Projections for Sustainability

(2-303) Assessing Interventions After Identification of Prolonged Corrected QT Intervals

(2-304) Comparing Characteristics Among Black Heart Failure with Reduced Ejection Fraction (HFrEF) Patients Based on Renin-Angiotensin System (RAS) Inhibitor Use at a Veterans Affairs Medical Center

(2-305) Impact of Pharmacist-Led Interventions as Part of a Clinical Rounding Team

(2-306) Mapping Georgia Community Pharmacies and Clinics: An Evaluation of Healthcare Utilization and Care Access Points

(2-307) Mapping Georgia Community Pharmacies and Clinics: An Evaluation of Kidney Disease Outcomes and Access to Care

(2-308) Benzodiazepine Use Within 72 Hours of Intubation in Intensive Care Unit (ICU) Patients After De-emphasizing Benzodiazepine Use in a Mechanical Ventilation Order Set

(2-309) Analgosedation Practices and Delirium in Patients Receiving Neuromuscular Blocking Agents

(2-310) Achievement of Electrolyte Targets with a Nurse-Driven Electrolyte Replacement Protocol in Adult Intensive Care Unit Patients

(2-311) Adherence to a Nurse-Driven Bowel Regimen Protocol in Critically Ill Patients at an Academic Medical Center

(2-312) Evaluation of Corticosteroids Duration on Outcomes in Critically Ill Patients with COVID-19 at a Large, Urban Academic Medical Center

(2-313) Improving PharmD Student Confidence Discussing Social Determinants of Health (SDoH) Topics with Patients

(2-314) Evaluation on the Duration of Micafungin Use and De-escalation Following (1,3)-β-D-Glucan (BDG) Testing in Patients at an Academic Medical Center

(2-315) Resistance of Escherichia coli Urinary Isolates in Patients with Healthcare-associated Urinary Tract Infections Treated in the Emergency Department of a Community Hospital

(2-316) Evaluation of Trough-Based Vancomycin Protocol in Adult Intensive Care Unit (ICU) Patients at an Academic Medical Center

(2-317) Trough-Based Monitoring for Vancomycin Dosing in the Non-Intensive Care Patient Population at an Academic Medical Center

(2-318) Resistance of Escherichia Coli Urinary Isolates in Patients with Community-acquired Urinary Tract Infections Treated in the Emergency Department of a Community Hospital

(2-319) Discrepancy in Vancomycin Minimal Inhibitory Concentration Per Vitek 2 and E-Test in Methicillin-Resistant Staphylococcus Aureus Bloodstream Isolates

(2-320) Review of Antimicrobial Changes Made in a Safety Net Health System Community Outpatient Antimicrobial Therapy Program

(2-321) Implementation and Evaluation of a Pharmacist and Nurse Driven Electrolyte Replacement Protocol at an Infusion Center

(2-322) Assessment of Molecular Profiling Results and Time to Treatment in the Lung Cancer Population

(2-323) Assessment of Pharmacy Student Skills upon Entering Advanced Pharmacy Practice Experiences

(2-324) Assessment of Summer 2022 Pharmacy Dispensing Log for Mobile Pharmacy Clinic in the Farm Worker Family Health Program in Rural Southwest Georgia

(2-325) Oxycodone Prescriptions upon Hospital Discharge for Kidney Transplant Recipients

(2-326) Geographic Accessibility to Contraceptives and the Potential Impact of Pharmacist Prescribing: Comparing Georgia Counties with Majority Non-white versus Majority White Demographics

(2-327) Evaluation of Appropriate Prescribing of Statins in Type 2 Diabetics After Recommendations Made by Pharmacy in Academic Medical Center and Medical Associates Clinics

(2-328) Evaluation of Amiodarone Use for the Prevention of New Onset Post-Operative Atrial Fibrillation in Cardiac Surgery Patients

(3-001) Medicare Prescribing Trends of Canagliflozin and Empagliflozin Nationally and in Hawaii from 2013 to 2020

(3-002) Medicare Prescribing Trends of Statins, Fibrates, and Omega-3 Fatty Acids from 2013 to 2020

(3-003) Comparison of Antibiotic Prescribing Trends and Clostridiodes difficile Infection (CDI) Rates in the United States from 2019-2020

(3-004) An Analysis of FDA Approved Drugs from 2018-2022

(3-005) Prevalence of Potentially Inappropriate Medications for Older Adults on Cardiovascular and Endocrine Drugs in a Family Medicine Clinic

(3-006) Comparison of Furosemide Prescribing and Heart Failure Hospitalizations by State from 2017 to 2019

(3-007) Comparative Health Behavioral Analysis Between Filipino Adults and Caucasian Adults in Hawaii with Association to Diabetes, Overweight, and Obesity Prevalence

(3-008) Examining Naloxone Distribution in Accordance with Prescription Opioid-Related Deaths

(3-009) Evaluation of Potentially Inappropriate Nonbenzodiazepine Receptor Agonist Hypnotics Prescribing Among the Elderly Medicare Patients by Prescriber Type in the United States and Hawai’i

(6-007) 2022 Incoming Fellows Recruitment Timing and Decisions Characteristics

(3-011) COVID-19 Vaccines Impact on 2021 Coronavirus Disease 2019 (COVID-19) Related Deaths versus Hospitalizations by State

(3-012) Examining Prevention Quality Indicators (PQI), Cost, and Length of Stay for Diabetes Across Counties in Hawai’i

(3-013) Obesity and Diabetes Correlation and the Pharmacist’s Role in Diabetes Prevention Programs

(3-014) Evaluation of Lipid-Lowering Regimens in Patients with Diabetes Mellitus

(3-015) Comparison of Medicare Statin Prescribing and Stroke Deaths in the United States from 2017 to 2019

(3-016) Possible Azathioprine Induced Posterior Reversible Encephalopathy Syndrome (PRES) During the Management of Acute Exacerbation of Systemic Lupus Erythematosus (SLE)

(3-017) Assessing the Use of Insulin and Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus in a Primary Care Clinic

(3-018) Project ADVOCATE: Antibody Distribution via Outstanding Critical Attention to Treatment Effectiveness

(3-019) CONSTRUCT- Creating an Online Network Site and Teaching Repository Utilizing Case-based Trainings: Utilizing Backwards Design and the ECHO Model

(3-020) Impact of Pharmacist-Led Medication Reconciliation on a Pediatric Outpatient Population

(3-021) Desmopressin for Intracerebral Hemorrhage in Patients on Antiplatelet Agents

(3-022) Analysis of Direct-To-Industry Jobs Among 2021 Doctor of Pharmacy Graduates

(3-023) Comparison of Measured Glomerular Filtration Rate of Humanized Vancomycin Infusion versus Vancomycin Bolus Followed by Saline Infusion in Sprague-Dawley Rats

(3-024) Recommending over the Counter Products to Pregnant Patients: What Do Practicing Pharmacists and Healthcare Students Think?

(3-025) The Marine Pharmacology and Pharmaceuticals Pipeline in 2022

(3-026) The Effect of Daily Meditation on Stress, Mindfulness, Well-being, and Resilience in Student Pharmacists

(3-027) Impact of Social Determinants of Health on COVID-19 Vaccine Hesitancy Among Vulnerable Populations

(3-028) The Impact of Mental Health During the COVID-19 Pandemic

(3-029) Continuation of Antipsychotics Initiated in the ICU at Unit Transfer and Hospital Discharge

(3-030) Evaluation of Intravenous Regular Insulin Use and Subsequent Hypoglycemia During Treatment of Hyperkalemia in a Large Multi-Site Hospital System

(3-031) An Evaluation of Outpatient Pediatric Asthma Prescribing Patterns in the United States

(3-033) Opioid Antagonist Utilization Patterns in U.S. Emergency Department Visits

(3-034) Assessment of National Trauma Trends for Motor Vehicle Accidents

(3-035) Paxlovid Eligibility in Patients Who Received Bebtelovimab for COVID-19 Treatment

(3-036) Metacognition of Interprofessional Education: Critical Discourse Analysis of an Interprofessional Healthcare Simulation

(3-037) Utilizing a Toxicology Digital Simulation Framed by the Pharmacists’ Patient Care Process to Prepare Students for Advanced Pharmacy Practice Experiences and Clinical Practice

(3-038) Evaluation of an Initial Tacrolimus Starting Dose After Simultaneous Kidney-Pancreas Transplant at a Large Academic Medical Center

(3-039) Impact of COVID-19 on the Academic Performance of Graduate Healthcare Students

(3-040) QTc Prolongation Observed with Haloperidol Administration in Hospitalized Patients

(3-041) Evaluation of Acetaminophen for Patent Ductus Arteriosus in the Neonatal Intensive Care Unit

(3-042) Student Pharmacist Interest in a Pharmaceutical Industry Preparation Elective Course: A Cross-sectional Survey

(3-043) Patient Perceptions of Student Pharmacist Communication and Roles in Pharmacy Practice

(3-044) Evaluating the Impact of Vaccine Education on Vaccine Hesitancy in African American Mothers

(3-045) Assessing Adherence to Guideline Recommendations on Initial Selection of Pharmacological Treatment for Hypertension at a General Internal Medicine Clinic in Metropolitan Central Illinois

(3-046) Impact of Clinical Service Integration with Pharmacy Students on Pharmacist Cost Savings

(3-047) Evaluation of Teaching Methods for Pharmacist Documentation

(3-048) Assessment of the Citation Frequency of Retracted Articles in Medical Literature

(3-049) Impact of Antimicrobial Stewardship Services in a Community Teaching Hospital

(3-050) Gram-Negative Bacteremias: Frequency of an IOTA (Intravenous to Oral Transition of Antimicrobial Therapy)

(3-051) Clinical Impact of a Pharmacist-led, Multidisciplinary Pain Management Service in a Primary Care Setting: A Retrospective Review

(3-052) Impact of Dexmedetomidine Initiation on Cardiovascular and Oxygenation in Critically Ill Preterm Neonates

(3-053) Analyzing Drug Interactions with Risk of QT Prolongation and the Utility of the Tisdale Scoring System

(3-054) Evaluation of a Pharmacist-Led Opioid Use Disorder Treatment Service: A Retrospective Cross-Sectional Study

(3-055) Evaluation of Safety and Efficacy of Tenecteplase for Acute Ischemic Strokes: A Retrospective Study

(3-056) U.S. Schools of Pharmacy Application and Expense Landscape and the Effect of COVID-19

(3-057) Sucralfate Slurry for the Treatment of Gastric Ulcers in a Patient with Dysphagia

(3-058) Development and Implementation of a Student Led Project to Optimize Financial Assistance for Patients Treated with Oral Anticancer Agents in a Health System Specialty Pharmacy

(3-059) Coronavirus Disease 2019 (COVID-19) Vaccination Rates Among Incarcerated Patients with Hepatitis C Virus (HCV) Infection

(3-060) Single-center Analysis of the Effects of a Video Education Intervention on Immunosuppressant Adherence in Kidney Transplant Recipients

(3-062) Impact of a Student-Run Warfarin Education Program on Post-Hospital Discharge Follow-Up Appointments

(3-063) Mail Order Outcomes in Kidney Transplant Cohort

(3-064) Impact of Clinical Research Design Elective Course on Students' Confidence in Research Skills

(3-065) Outpatient Pharmacy Management of Dispensing Extended-Release Injectable Buprenorphine for Opioid Use Disorder at a Federally Qualified Health Center

(3-066) Comparative Analysis of Phenobarbital and Non-Phenobarbital Based Alcohol Withdrawal Syndrome Regimens

(3-067) Barriers to Naloxone Dispensing in Community Pharmacies: Comparing Results from a 2021 and 2022 Educational Outreach Initiative

(3-068) Perioperative Desensitization with Intravenous Immunoglobulin vs. Bortezomib in Positive Crossmatch Deceased Donor Kidney Transplants: 12-Months Outcomes Analysis

(3-069) Evaluation of Ambulatory Care Pharmacist-led Nirmatrelvir/Ritonavir Prescribing on Rates of Hospitalization for COVID-19

(3-070) The Safety and Tolerability of High Dose Intravenous Push Levetiracetam

(3-071) Intravenous High Dose Hydrocortisone versus Intravenous Low Dose Hydrocortisone in Patients with Septic Shock

(3-072) Delirium in the Intensive Care Unit – Analysis on the Prescribing and Deprescribing Rates of Quetiapine

(3-073) Swabbing Our Way to Better Stewardship: The Impact of Pharmacist Driven MRSA Nares PCR Protocol on Duration of Vancomycin Therapy for Pneumonia

(3-074) Evaluation of Rituximab Use at Parkview Health

(3-075) Appropriateness of Outpatient Management of Urinary Tract Infections at an Urban, Safety-Net, Academic Medical Center

(3-076) Antibiotic Use and Appropriate Indications in Community Acquired Pneumonia (CAP)

(3-077) Assessing a Novel Education Tool to Improve Knowledge and Reduce Stigma of a Syringe Service Program (SSP) for Substance Use at the Indianapolis VA

(3-078) Inducing Alternative Forms of Cell Death in Multi-Drug Resistant Ovarian Cancer Cells

(3-079) Evaluation of Intensive Care Unit (ICU) Medication Transitions of Atypical Antipsychotics

(3-080) When Slow and Steady State Does Not Win: Initial Peak Anti-Xa Levels in Enoxaparin for Venous Thromboembolism (VTE) Prophylaxis in Burn Patients

(3-081) Evaluation of Therapies for Treatment of Hyponatremia

(3-082) Evaluation of Epoetin Alfa Use in End Stage Renal Disease at University of Louisville Health

(3-083) Impact of Optimizing Smart Infusion Pump Dose Error Reduction Systems (DERS) on Opioid Ordering for Naïve versus Tolerant Patients

(3-084) Roles of Alternative Splicing and Differential Expression in Fluoxetine Response

(3-085) Concordance of Indexed Medical Subject Headings with Clinician-generated Population, Intervention, Comparison, Outcome (PICO) Terms

(3-086) Scope and Completeness of Drug Information for Pregnancy and Lactation in Electronic Tertiary Databases

(3-087) Characterization of Vancomycin Use at a Community Hospital

(5-059) A Medical Use Evaluation for Clostridioides difficile Infection Treatments at a Community Hospital

(3-089) Continued Use of Proton Pump Inhibitors and Risk for Recurrence of Clostridium Difficile Infection-A Retrospective Study

(3-090) Fidaxomicin Use for Initial and Recurrent Clostridioides Difficile Infections at a Community Hospital in Northern Indiana

(3-091) Enhanced Recovery After Surgery (ERAS): Multimodal Pain Regimen in Heart Transplant and Left Ventricular Assist Device Surgery

(3-092) Evaluation of Laboratory Protocol for Cerebral Spinal Fluid Specimens to Identify Opportunities to Optimize Diagnostic Reflex Testing with Polymerase Chain Reaction in Meningitis Patients

(3-093) Evaluation of Cytochrome P450 Inhibition by the Synthetic Cathinones Butylone and MDPPP

(3-094) Efficacy of Transitions of Care Management (TCM) Services in Reducing Hospital Readmission Rates

(3-095) Diabetic Services Surveys

(3-096) Assessing Anticoagulation Management in Patients on Concomitant Rifampin

(3-097) Incidence of Hypertriglyceridemia in ICU Admitted COVID-19 Who Received Propofol for Mechanical Sedation

(3-098) Health Equity Language Within Residency Training Promotional Content

(3-099) Evaluation of Treatment of Alcohol Withdrawal in a Community Hospital

(3-100) Ask-Advise-Refer to the Tobacco Quitline: Implementing Brief Tobacco Cessation Interventions During Community-Based Health Events

(3-101) Symptom Guided Recommendations to Support Clinical Decision Making in Deprescribing Anticholinergic Antidepressant Medications

(3-102) Implementation of 5S Methodology in a Central Pharmacy at a Large Academic Hospital

(3-103) Evaluation of Post-Surgical Discharge Amiodarone Monitoring and Toxicities at a Cardiac Care Center in the United Kingdom

(3-104) Adherence to Secondary Preventative Medications Following Acute Myocardial Infarction

(3-105) Evaluation of Pharmacy Intervention and Utilization of Indiana University Health Methodist Hospital’s Meds in Hand Program at Discharge from the Cardiac Progressive Care Unit

(3-106) Evaluation of Epinephrine Use as a Push-dose Vasopressor in the Non-operating Room Setting

(3-107) Comparison of Self-Reported Medication Inventory and Medication Orders Data Among Elderly Anticholinergic Users for Quantification of Medication Risks

(3-108) Medication Use Evaluation of Ceftriaxone Prescribing Practices in Community Acquired Pneumonia and Urinary Tract Infection at a Large Single-Center Institution

(3-109) Evaluation of Perampanel for Refractory Status Epilepticus or Super-Refractory in the Neurological Intensive Care Unit at an Academic Medical Center

(3-110) Evaluation of Guideline Recommended Treatment Duration for Hospitalized Patients Diagnosed with Uncomplicated Community Acquired Pneumonia

(3-111) Evaluation of Naloxone Use and Opioid-induced Unintended Sedation Monitoring Practices at an Academic Medical Center

(3-112) Potential Impact of Preemptive Pharmacogenetic Testing in Critically Ill Neonates

(3-113) Trends in Toxicologic Exposures Requiring Pediatric Intensive Care Unit Admission Pre and During COVID-19

(3-114) Assessing the Effect of Calibrated Peer Review on Student Pharmacist Confidence with the Pharmacists’ Patient Care Process

(3-115) Evaluation of Healthcare Learners’ Self-Assessments Surrounding an Interprofessional and Culturally-Focused Simulation Activity

(3-116) Current Status of Tobacco Cessation Education in Doctor of Pharmacy Programs in the U.S

(3-117) Evaluating Social Media as a Pharmacovigilance Monitoring Tool

(3-118) Evaluating Accuracy of Adverse Drug Reaction Reporting in a Health System's Ambulatory Infusion Setting

(3-119) Improving the Safe Dispensation of Oral Methotrexate for Non-Oncological Purposes in a Primary Care Center Pharmacy

(3-120) Evaluation of the Safety of Direct-acting Oral Anticoagulants vs. Warfarin for Portal Vein Thrombosis Anticoagulation After Liver Transplant

(3-121) Evaluation of Contraindications and Precautions in a Pharmacist Hormonal Contraception Prescribing Service

(3-122) Evaluation of Risankizumab Use in Daegu Catholic University Medical Center

(3-124) National Strategies to Optimize Taiwan's Drug Supply Chain and Mitigate Drug Shortages Amid COVID-19 Pandemic

(3-125) Psoriasiform Inflammation Is Associated with Mitochondrial fission/GDAP1L1 Signaling in Macrophages

(3-126) Growth Evaluation After Using Postnatal Dexamethasone in Very Low Birth Weight (VLBW) Infants

(3-127) Evaluation of Health-Related Information Seeking Behavior Through the Internet in Korean Adults: A Cross-Sectional Survey

(3-128) Predictive Factors of Searching Dietary Supplements Through the Internet Among Korean Adults

(3-129) Validation of Media Health Literacy Evaluation Tool for Korean Adult

(3-130) Development and Validation of a Medication-based Fall Risk Prediction Model in Community-dwelling Elderly Using a National Claims Database – a Machine Learning Approach

(3-131) Assessing Visitors’ Satisfaction of Smoking Cessation Clinics and Services: A Cross-sectional Study in Saudi Arabia

(3-132) Biomarkers in Alzheimer´s Disease: Clinical Aspects

(3-133) Proton Pump Inhibitors Alone or in Combination with Octreotide in Upper Gastrointestinal Bleeding: A Retrospective Observational Study

(3-134) Pharmacist-led Identification of Drug-Related Problems in Discharge Patients: A Cross-Sectional Study

(3-135) Accuracy of A1c Testing When Conducted Through Capillary Point-of-care Testing Machines as Compared to Venous Blood Draw

(3-136) Assessment of Pharmacy Staff Knowledge on Access to Language Services to Complete Inpatient Medication Reconciliations at a 2,000 Bed Academic Medical Center

(3-137) Integration of Pharmacy Students into Clinical Internships in the Workplace

(3-138) Evaluation of Heparin Line Labeling After Implementation of Process Improvement Initiatives

(3-139) Medication Use Evaluation of a Therapeutic Enoxaparin Collaborative Practice Monitoring Protocol

(3-140) Assessment of Warfarin Monitoring Outcomes After Implementation of an Optional Pharmacy Consult Service

(3-141) Heparin-induced Thrombocytopenia (HIT) Best Practice Alert (BPA) Overfiring

(3-142) Training Experiences of Postgraduate Year 2 Pain Management and Palliative Care Pharmacy Residency Graduates

(3-143) Improving Pharmacist Efficiency and Efficacy in Hypertension Management with Use of a Remote Blood Pressure Monitoring System​

(3-144) Evaluation of Inpatient Use of Eculizumab, a Restricted Formulary Drug

(3-145) Rare Spontaneous Candida Albicans Peritonitis in a Patient with Chronic Alcohol Abuse and Liver Disease: A Case Presentation

(3-146) Evaluation of Alaris® Infusion Pump Integration Compliance Within Saint Luke’s Health System

(3-147) Real-world Maintenance Rituximab Dosing Practices in Patients with ANCA-associated Vasculitis

(3-148) What’s Neu with HER2? Characterization of HER2-Low Breast Cancer Tumors and Genomes

(3-149) Improving the Prediction of Cefepime-induced Neurotoxicity in Critically Ill Patients: Risk Factor Exploration of a Neurotoxicity Prognostic Tool

(3-150) Thematic Analysis of Student Perception of a Social Determinants of Health and Disparities Simulation Activity

(3-151) Accessibility of Diabetes Therapy for Patients with Visual Impairment

(3-152) Accessibility of Ocular Drug Product Websites

(3-153) Systematic Review and Formulary Evaluation of Acute Treatment Options for Hereditary Angioedema in a Large Academic Medical Center

(3-154) Evaluation of Smart Pump Dose Error Reduction Systems at a Large Academic Health System

(3-155) Proposed Cost Savings at a Health System If Monoclonal Antibodies Are Rounded down to the Nearest Vial Size Within Ten Percent of the Prescribed Dose

(3-156) Evaluation of a Hypoglycemia Protocol in Newborns at a Community Hospital

(3-157) Evaluation of Indomethacin and Acetaminophen for Patent Ductus Arteriosus (PDA) Closure in Preterm Neonates

(3-158) Evaluation of Prescribing Frequency of Range Orders That Comply with Revised Organization Policy at an Academic Medical Center

(3-159) Evaluation of a Monthly Audit Tool for Automated Dispensing Cabinets in Patient Care Units at a Large Academic Medical Center

(3-160) Evaluation of Rabbit Anti-Thymocyte Globulin Induction Dosing in Renal Transplant Patients Using Actual Body Weight versus Ideal Body Weight

(3-161) Topical vs Oral Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Safety Medical Use Evaluation

(3-162) Evaluation of Sugammadex Use at a Community Hospital

(3-163) Quality Improvement Study: Colorectal Surgery Implementing Opioid Prescribing Limits

(3-164) Amiodarone Induced Thyrotoxicosis

(3-165) Availability of Pharmacist Care Services in Medically Underserved Areas in Kentucky via Board-approved Protocols

(3-166) Case Report: Methylphenidate for Hypoactive Delirium in the Intensive Care Unit

(3-167) Targeted Thrombolytic Therapy Delivered via Pulmonary Artery Catheter for Massive Pulmonary Embolism

(3-168) Progression of Kidney Injury with the Combination of Vancomycin and Piperacillin-Tazobactam or Cefepime in Sepsis-Associated Acute Kidney Injury

(3-169) Impact of the COVID-19 Pandemic in the Rates of Depression and Anxiety Across the United States: A Systemic Review

(3-170) History of Antibiotic Adverse Reactions and the Incidence of Asymptomatic Bacteriuria Treatment at a Single Veterans Affairs Health Care System

(3-171) Medication Use Evaluation of Methylnaltrexone at a Rural, Community Hospital

(3-172) Profile of Adverse Drug Reactions Reported with Empagliflozin at a Single Veterans Affairs Health Care System

(3-173) Evaluation of Patients Admitted Through the Emergency Department for Low Risk Pulmonary Embolism

(3-174) Does Droperidol Work for Every Ailment? Droperidol for the Management of Phantom Limb Pain: A Case Report

(3-175) Impact of Patient Demographics and Social History on Propofol Dosing for Procedural Sedation in the Emergency Department

(3-176) Comparison of Hepatitis C Treatment Outcomes Between Transplant and Non-Transplant Patients

(3-177) Antimicrobial Management of Methicillin-Susceptible Staphylococcus aureus (MSSA) Bacteremia Complicated by Myocardial Abscess and an Infected Coronary Stent

(3-178) Characterization of Trends in Infectious Diseases Service Referrals to Outpatient Parenteral Antimicrobial Therapy (OPAT) Team with a Focus on Patient Eligibility and Outcomes

(3-179) Novel Pharmacogenetics Mobile Application as an Educational Intervention for Patients and Providers

(3-180) Assessing Appropriate Initiation of Parenteral Nutrition in Patients Admitted to a Community Health System

(3-181) Perioperative Management of Hemophilia B

(3-182) Pharmacist’s Potential to Use Pharmacogenomics to Tailor Perioperative Pain Management

(3-183) Evaluation of Fentanyl Patch Use Among Prescribers at University of Louisville (UofL) Health

(3-184) Characterization of Awareness and Depth of Blockade During Neuromuscular Blockade Infusions in Children

(3-185) Use of Pharmacokinetic Monitoring to Assess Acute Kidney Injury Risk in Vancomycin and Piperacillin-Tazobactam Combination Therapy

(3-186) Mixed Methods Analysis of Memantine Misuse Trends Identified Through a Social Media Mining Method

(3-187) Correlation of Pharmacy School Grade Point Average (GPA) to Post-Graduate Year Two (PGY2) Interview Offer

(3-188) Adverse Drug Reactions Reported Following a Mandatory Formulary Conversion: Symbicort vs. Wixela

(3-189) Evaluation of Time to Treatment Among Specialty Medications Transferred to External Specialty Pharmacies

(3-190) Volume Loss in Liquid Medications Using Different Dispensing Configurations

(3-191) Evaluating a Rare Case of Bifidobacterium Bacteremia and Suspected Neurosyphilis

(3-192) Implementation of Team-Based Learning in Pharmacy School Courses: A Systematic Review

(3-193) Critical Care Residents' Perception of a Virtual Interview and Search Process and Its Impact on PGY2 Program Selection

(3-194) Treatment with Very Low Dose Nilotinib Due to Adverse Events Results in Prolonged Major Molecular Response

(3-195) Evaluation of Suspected Bacterial Sepsis Work-Up and Initial Antibiotic Therapy in a Pediatric Cardiac Intensive Care Unit

(3-196) Implementation of Indications on Meropenem Orders in the Electronic Medical Record to Improve Antibiotic Use

(3-197) Evaluation of the Efficacy and Safety of Direct Oral Anticoagulants (DOACs) versus Warfarin in Obese and Morbidly Obese African American (AA) Patients

(3-198) Inhibition of Alpha-glucosidase by Aloe Vera Plant (Aloe Barbadensis Miller) as an Antidiabetic Mechanism of Action

(3-199) Continuation Rate of Newly Initiated Midodrine During Intensive Care at Hospital Discharge

(3-200) Present Perceptions of Mistrust in Medical Treatment and Vaccination Among African Americans During the COVID-19 Pandemic

(3-201) Perceived Role and Identity of Pharmacists and the Potential Impact on COVID-19 Vaccine Uptake Per Louisiana Region: A Prospective Cohort Study

(3-202) Designing and Testing the Knockdown Efficacy of siRNAs Specifically Targeting the ERα36 Isoform in HEK293T Cells That Stably Express ERα36-GFP

(3-203) Appropriate Use of Zoledronic Acid for Oncologic Indications

(3-204) Evaluation of Intravenous N-Acetylcysteine for the Treatment of Pediatric Acetaminophen Toxicity

(3-205) Evaluating Student Pharmacists’ Perceptions on Immunization Communication

(3-206) Barriers to Electronic Prescribing of Opioids

(3-207) Examining the Effects of the COVID-19 Pandemic on Mental Health Among First Year Pharmacy Students

(3-208) Pharmacists' Role in Improving Outcomes for Diabetic Neuropathy

(3-209) Evaluating Appropriate Statin Therapy in Diabetic Patients in Regards to Age, Smoking Status, A1c, and ASCVD Risk

(3-210) Stability of Multi-Ingredient Preparations Intended to Relieve Pain

(3-211) Continuation Rate of Newly Initiated Stress Ulcer Prophylaxis in the Intensive Care Unit at Discharge

(3-212) Medication Use Evaluation of Rasburicase for Tumor Lysis Syndrome (TLS) in Pediatric Oncology Patients

(3-213) Trends of COVID-19 Vaccination Among Louisiana Pharmacies from May 2021 to May 2022: A Prospective, Cohort Study

(3-214) Silmitasertib (CX-4945) Facilitates Proteasome-Mediated Degradation of Estrogen Receptor (ER) and Alters the Expression of a Panel of Genes Involved in Estrogen Receptor Signaling Pathway

(3-215) Assessing the Knowledge and Perceptions of Coronavirus Disease-19 (COVID-19) Vaccines Among Fourth Year Student Pharmacists

(3-216) Continuation Rate of Newly Initiated Propranolol in the Intensive Care Unit at Hospital Discharge

(3-217) Evaluation of Durations of Discharge Antibiotic Prescriptions for Community-Acquired Pneumonia

(3-218) Compensation for State Board of Pharmacy Members

(3-219) Metformin Reduces Atypical Antipsychotic-Associated Weight Gain in Adults

(3-220) Collaboration Across Specialties in a Pharmacists Led Pharmacogenomic Initiative Within a Community Health-System

(3-221) Continuous Glucose Monitoring and Effects on HbA1c in Patients Diagnosed with Type 2 Diabetes

(3-222) Evaluation of in Vitro Antimicrobial Resistance Selection in Salmonella Enterica Serovar Typhi (Salmonella Typhi)

(3-223) Evaluation of a Pharmacist-Driven Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab Protocol

(3-224) Collaborative Practice Agreement for Chemotherapy-Induced Nausea and Vomiting: Pharmacist Impact on National Guideline Compliance and Patient Outcomes

(3-225) Evaluation of Appropriateness of Guideline Directed Medical Therapy in Chronic Heart Failure Patients Admitted to Observational Unit in a Community Hospital

(3-226) Medication Management Clinic Participation in Discharge Rounds Improves Resolution of Medication Cost Barriers Prior to Discharge in a Community Hospital

(3-227) Correlation of PHQ-9 Scores with HIV Outcomes Before and During the COVID-19 Pandemic

(3-228) Selecting a Glucagon-Like Peptide- 1 Receptor Agonist versus Sodium-Glucose Co-Transporter-2 Inhibitor for Secondary Prevention of Major Cardiovascular Events Post-Stroke

(3-229) Evaluation of Guideline Driven Heparin Induced Thrombocytopenia Antibody Testing Within a Health System

(5-255) A Systematic Review of Emerging Alternative Payment Models (APMs) Used for Oncologic Treatment in the United States

(3-231) Assessing Effects of Cannabis, Cannabinoids and Their Metabolites on the Pharmacokinetics of Antiretroviral Therapy (ART)

(3-232) Analysis of Pharmacist’s Understanding of Oral Health/Denture Management and Its Impact on Patient Outcomes

(3-233) Assessing the Effects of Antibiotics on the Gut Microbiome

(3-234) Effects of COVID-19 Pandemic on Spirituality and Resilience in Health Professional Students

(3-235) Retrospective Review of the Safety and Efficacy of Using IV/IM Droperidol in a Community Hospital Emergency Department

(3-236) Impact of a Pharmacy Integration in Discharge Rounds on Addressing Medication Discrepancies Prior to Discharge and Readmissions at a Community Hospital

(3-237) Missed Opportunities for Optimization of Cholesterol Management in Clinical Atherosclerotic Cardiovascular Disease

(3-238) Prophylactic Amiodarone Use in the Management of Postoperative Atrial Fibrillation at Luminis Health Anne Arundel Medical Center

(3-239) Evaluation of Intensities of Anticoagulation for Thromboprophylaxis in Coronavirus Disease 2019 (COVID-19) Infected Intensive Care Unit (ICU) Patients

(3-240) Review of Accelerate-Pheno Implementation and De-Escalation for Bacteremia at MedStar Union Memorial Hospital and MedStar Good Samaritan Hospital

(3-241) Evaluating Outpatient Vancomycin Monitoring and the Incidence of Nephrotoxicity

(3-242) Retrospective Chart Review of De-Escalation of Vasopressin in Patients with Septic Shock

(3-243) Anti-obesity Weight Loss Medications: Short-term and Long-term Use

(3-244) Evaluation of Drug Delivery Efficacy in Neuroblastoma Using in Vitro Models

(3-245) Evaluation of Fibrinolytic-associated Adverse Drug Events in Acute Ischemic Stroke

(3-246) Comprehensive Pharmacist-led Transitions-of-care Medication Management Intervention for Older Adults Around Hospital Discharge: A Time-and-Motion Analysis of Resources and Costs

(3-247) Assessing the Impact of Social Determinants of Health in Patients with Opioid Use Disorder in the Primary Care Setting

(3-248) Enoxaparin Anti-Xa Monitoring in Obese Patients with Acute Venous Thromboembolism

(3-249) Systematic Review and Bayesian Network Meta-analysis of Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors on Cardiovascular Outcomes

(3-250) Nirmatrelvir/ritonavir Drug Interactions : What Should We Know?

(3-251) Change in Invasive Hemodynamic Markers with Use of Intravenous Octreotide in a Patient with Pulmonary Hypertension: A Case Report

(3-252) Novel Uses of Ketamine

(3-254) Effect of Sotrovimab on Hospitalization, Mortality, and COVID-19 Progression in High Risk Outpatients: An Exploratory Meta-analysis

(3-255) Concern for Resistance to Pneumocystis Jiroveci Pneumonia Case Report

(3-256) Utility of Ursodiol for SOS/VOD Prophylaxis in Acute Leukemia Patients Receiving Gemtuzumab-Ozogamicin (GO) or Inotuzumab-Ozogamicin (InO)

(3-257) Inhibitory Effect of SCH-79797 on Cell Proliferation of the A549 Lung Adenocarcinoma Cell Line

(3-259) Assessing the Effectiveness of Rapid PCR Testing in Decreasing Time to De-escalation for Staphylococcus aureus Bacteremia in a Community Hospital

(3-260) Characterization of Extravasation Events from Peripherally Administered Vasopressors at a Community Hospital

(3-261) Evaluation of Patients’ Satisfaction and Preferences in Telemental Health Services: A Survey Study

(3-262) Transition to Once Weekly Tirzepatide After Severe Nausea and Vomiting One Year After Successful Treatment with Both Semaglutide and Exenatide LAR Once Weekly

(3-263) Pravastatin for Radiation-Induced Fibrosis Pain

(3-264) Evaluating Health Outcomes Associated with Concordant Language Interactions Between Diabetic Hispanic Patients and Providers

(3-265) Comparing Geographical Disparities of COVID-19 Vaccines: Evaluation of Rural vs Urban Areas

(3-266) Dysregulated Biological Processes in Pancreatic Ductal Adenocarcinoma Cancer (PDAC) Patients Treated with FOLFIRINOX as Standard Chemotherapy

(3-267) Pancreatic Cancer: Tumor Location and Likelihood of Diabetes as a Comorbidity

(3-268) Analyzing the Effectiveness of Social Stories for Behavioral Modifications in Autistic Children and Its Applicability in the Pharmacy Setting

(3-269) Social Stories for Targeting Medication Adherence and Tolerability in Pediatric Patients with ASD

(3-270) Pharmacogenomic Review of the Clinical Implications of CYP2B6 Polymorphisms on Methadone Therapy

(3-271) Differentially Expressed Genes in Subtypes of Pancreatic Ductal Adenocarcinoma and Beta Cell Development

(3-272) Efficacy of Drug Combination Regimens of Vancomycin or Daptomycin with Beta-lactam Antibiotics for Methicillin-resistant Staphylococcus aureus Infections

(3-273) Management of Carfilzomib-Induced Thrombotic Microangiopathy

(3-274) Hydrochlorothiazide-Induced Pulmonary Edema: Case Report

(3-275) Evaluating Use of Intranasal Esketamine in Treatment-Resistant Major Depressive Disorder (MDD) Treated Adjunctively with Oral Antidepressant

(3-276) Specialty Medication Utilization Project: Upadacitinib for the Treatment of Rheumatoid Arthritis

(3-277) Examining the Association Between COVID-19 Infection and Worsening Diabetes Mellitus

(3-278) The Opioid Epidemic and the Forgotten Population

(3-279) The Effectiveness of Pharmacist Telemedicine Services

(3-280) Utilization of Targeted Nanoparticles to Improve Therapeutic Outcomes in Management of Retinoblastoma

(3-281) BCMA in Vitro Assays to Evaluate Nanotherapeutics for Multiple Myeloma Treatment

(3-282) Finerenone and Empagliflozin Use for Chronic Kidney Disease with Albuminuria in a Patient with Type 2 Diabetes and Hypertension

(3-283) The Effects of Hypertension on Patients from a Low-income Population

(3-284) Comparing Community Hospital Protocols and National Institutes of Health Guidelines Regarding the Use of Interleukin-6 Inhibitors in Hospitalized COVID-19 Patients

(7-185) A Survey of Family Practice Physicians Regarding Referral for Diabetes Self-Management Education and Support in Type 2 Diabetes

(3-286) Targeted Therapy for Malignant Rhabdoid Tumors via SMARCB1-Mutation Mediated Pathways

(3-287) Case Report of Possible Bloating and Abdominal Pain After a Manufacturer Change of Dextroamphetamine Tablets in a Patient with Celiac Disease

(3-288) Biopharmaceutical and Digital Health Partnerships on Promoting Adherence to Diabetes Medications

(3-289) Tocilizumab Treatment: A Potential New Option for Scleroderma Patients

(3-290) Safety and Efficacy Analysis of High-Dose Methotrexate Use in Adult Patients with High-Grade Primary Osteosarcoma: A Systematic Review

(3-291) Where to Go When You Need to Know?: A Meds to Beds Tool to Improve Visibility of Order Progress

(3-292) Design, Synthesis, and Assay of Novel Compounds for the Treatment of Chagas Disease

(3-293) Efficacy of a Digoxin Load Order Panel for Atrial Fibrillation or Flutter with Rapid Ventricular Response

(3-294) Inappropriate DOAC Dosing in Older Adults and Clinical Outcomes

(3-295) Paliperidone Induced Hepatotoxicity in a 61-year-old Patient

(3-296) Droperidol and QTc Prolongation in the Emergency Department: A Retrospective Observational Study

(3-297) Review of Antiretroviral Stewardship Practices at a Tertiary Academic Medical Center

(3-298) Implementation of a Longitudinal Pharmacy Student Patient Education Service Pilot at a Large Academic Medical Center

(3-299) Evaluation of National Practices for PGY1 Pharmacy Residency Emergency Response

(3-300) InsPIRe-Me: Industry Pharmacy Initiative for PharmD Students to Reach Their Goals Through Fellow Mentorship

(3-301) Rate of Adherence to Lamotrigine Titration Schedules with or Without Drug-Drug Interactions at an Inpatient Psychiatric Facility

(3-302) Pharmacogenomic Testing in Patients with Major Depressive Disorder: Global versus U.S. Perspective

(3-303) Impact of Polypharmacy on Time in Therapeutic Range for Older Adults with Atrial Fibrillation Taking Warfarin

(3-304) Evaluation of the Safety of Inpatient Utilization of Empagliflozin

(3-305) Impact of Overlapping Cognitive Impairment and Physical Frailty on Oral Anticoagulant Therapy Outcomes in Older Atrial Fibrillation Patients

(3-306) Overview of Direct-to-Consumer Pharmacies and Their Role in Pharmacy Practice

(3-307) Systematic Review of the Effectiveness of Telepharmacy Services in Ambulatory and Community Pharmacy

(3-308) Optimizing Heart Failure Guideline Directed Medical Therapy Utilization by Enhancing Transitions of Care

(3-309) Effect of Pharmacist-Led Interventions on Diabetes Distress Among People with Type 2 Diabetes in a Community Care Setting

(3-310) Effect of Combination Therapy with Ceftaroline versus Standard of Care on Time to Clearance of Persistent Methicillin Resistant Staphylococcus aureus Bacteremia

(3-311) Evaluation of Azithromycin Dosing Regimens at an Academic Medical Center

(3-312) Prophylactic Use of Oral Vancomycin in Hospitalized Patients at Risk for C. Difficile

(3-313) Exploring the Pharmacist’s Role in the Future of Technology in the Healthcare System

(3-314) Optimizing the Potential of Zafirlukast as an Antithrombotic Agent Through the Creation of Second-generation Analogs

(5-001) Assessing the Impact of Pharmacist-Initiated Staphylococcus Aureus Nasal PCR Protocol on Vancomycin Use in Non-purulent Cellulitis

(5-002) Assessment of Comprehensive Medication Management Incorporating a Patient Self-completed Medical/Medication Form

(5-003) Novel Beta-Lactam/Beta-Lactamase Inhibitor Combination Use in Morbidly Obese Patients with Pseudomonas Aeruginosa Pneumonia: Multicenter Evaluation of Clinical and Safety Endpoints

(5-004) Oncologic Maintenance Therapies in Progression-Free Populations: A Systematic Literature Review

(5-005) Implementation of a Primary Care Opioid Stewardship Team Reduces Morphine Milligram Equivalents in Patients on Chronic, High-Dose Opioid Therapy

(5-006) Retrospective Chart Review Comparing Safety and Efficacy of Direct Oral Anticoagulants versus Warfarin in Patients Diagnosed with Liver Impairment

(5-007) Infectious Diagnoses and Antibiotic Concordance Compared Between White and Non-White Populations Within Three Michigan Health Systems

(5-008) Telemedicine Antibiotic Prescribing Trends Pre and Post COVID-19 Pandemic in Michigan

(5-009) Impact of a Less Time Intensive Leadership Development Elective on Pharmacy Students

(5-010) Differences in the Approach to Guideline Directed Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction: A Survey of Cardiologists, Internists, and Pharmacists

(5-011) Human Papillomavirus (HPV) Vaccination: First-Year College Students' Beliefs & Attitudes

(5-012) Use of Infliximab in Patients with Liver Dysfunction for the Treatment of Immune Checkpoint Inhibitor Toxicity

(5-013) Evaluation of the Use of Novel Agents for Sickle Cell Disease at an Academic Medical Center

(5-014) Treating Prehospital Pain in Children: A Retrospective Chart Review Comparing the Safety and Efficacy of Prehospital Pediatric Ketamine and Opiate Analgesia

(5-015) Clinical Impact of a Heparin Nomogram in a Pediatric Academic Medical Center

(5-016) Frequency of Possible Interactions Between Cannabis and Prescribed Psychotropics

(5-018) Adverse Drug Reactions and CYP2C19 Phenotype in SSRI Treated Patients with Neurodevelopmental Disorders

(5-019) Impact of Rurality and Age on Colorectal Cancer Screening Rates Among Michigan Residents

(5-021) Phage-Antibiotic Combinations Against Multidrug-resistant S. Aureus and E. Faecium: Protein Synthesis Inhibitors Antagonize Phage Activity

(5-022) Effectiveness of Etelcalcetide After Cinacalcet in End Stage Kidney Disease Hemodialysis Patients

(5-023) Sequential Dosing of Phage-Antibiotic Combinations in MDR Pseudomonas Aeruginosa

(5-024) High Definition Pharmacogenomics and Therapeutics for CYP3A4 and CYP3A5

(5-025) Evaluation of Differences in Payer-negotiated Prices Between Biosimilars and Originator Drugs

(5-026) Enhancing Resident-Preceptor Relationships Through Resilience Discussions

(5-027) Resident Physician Perceptions, Expectations, and Experiences with Ambulatory Care Pharmacists and the Services Provided in Outpatient Clinics at a Large Academic Medical Center

(5-028) Ticagrelor-Induced Syncope in Bradycardic Patient

(5-029) Serotonin Syndrome: Medication Reconciliation Pitfalls and Novel Risks

(5-030) Comparison of Insulin 5 Units versus 10 Units for the Management of Hyperkalemia

(5-031) High Dose Amphotericin Use in Various Fungal and Fungal-Related Infections

(5-032) Methicillin-Susceptible Staphylococcus aureus COVID-19 Superinfection: A Case Series

(5-033) Effect of Inappropriate Surgical Prophylactic Regimens on Surgical Site Infections in Intra-abdominal Surgeries

(5-034) Evaluation of a Pediatric Enoxaparin Dosing Protocol at Children’s of Mississippi

(5-035) Evaluation of Guideline Directed Pharmacotherapy in the Pediatric Hypertension Clinic

(5-036) Evaluating the Impact of Coronavirus Disease of 2019 (COVID-19) on Learning Opportunities and Communication Readiness in Introductory Pharmacy Practice Experience (IPPE) Students

(5-037) Evaluation of a Pediatric Community-Acquired Pneumonia Antimicrobial Stewardship Intervention at an Academic Medical Center

(5-038) Design and Development of New Dehli Metallo-β-Lactamase 1 Inhibitors to Combat Antibiotic-Resistant Bacteria

(5-039) Incidence and Management of Cytokine Release Syndrome and Neurotoxicity in Acute Lymphoblastic Leukemia Patients with Minimal Residual Disease Receiving Blinatumomab

(5-040) Adherence to Institutional Antimicrobial Dosing for Intensive Care Unit Patients on Continuous Renal Replacement Therapy

(5-041) Sodium Zirconium Cyclosilicate Utilization for Acute Hyperkalemia at an Academic Medical Center

(5-042) Retrospective Observational Cohort Study Evaluating the Use and Risks of Opioid Therapy in Patients Receiving Rehabilitation Treatment

(5-043) Impact of Pharmacist-Driven Messaging to Improve Guideline Directed Medical Therapy (GDMT) in Heart Failure with Reduced Ejection Fraction (HFrEF) Patients

(5-044) Evaluation of Prescribing Patterns for Sodium-Glucose Cotransporter Protein 2 (SGLT2) Inhibitors in a Primary Care Medicine Clinic

(5-045) Assessing the Use of Baricitinib as Treatment for Hospitalized Patients with COVID-19

(5-046) Evaluation of Automated Dispensing Cabinet Override Medication Use Within an Academic Health System

(5-047) Treatment Outcomes in Advanced Cancer Patients Receiving Immune Checkpoint Inhibitors and Concurrent Proton Pump Inhibitor Therapy

(5-048) Evaluating the Readability of Patient Level Educational Materials on Biosimilars Used in a Rheumatology Clinic

(5-049) Medication Use Evaluation of Undiluted Sodium Bicarbonate Continuous Infusions in Critically Ill Patients

(5-050) Therapeutic Interchange of Rifaximin in Acute Overt Hepatic Encephalopathy

(5-051) Impact of a Student Pharmacist Led Medication Counseling Program for Patients with Heart Failure in a Community Hospital

(5-052) Evaluating Early Use of Front-Loading Phenobarbital in Patients with Alcohol Withdrawal

(5-053) Evaluation of Hypoglycemia Incidence and Associated Risk Factors in Patients Treated with Intravenous Insulin for Acute Hyperkalemia Management

(5-054) Outcomes of a Mini-Desensitization Protocol with Docetaxel, Paclitaxel, or Carboplatin

(5-055) Neonatal Gentamicin Concentrations Following Maternal Once-Daily Gentamicin Dosing

(5-056) Treatment Evaluation of Uncomplicated Cystitis Infections

(5-057) Evaluating the Need for Standardized Electrolyte Management by Means of a Phosphorus Replacement Protocol in a Community Hospital

(5-058) Standardization of Oral Solution Naming for the Prevention of Medication-Related Dosing Errors upon Order Verification and Administration

(2-105) A Mock OSCE for First-Year Pharmacy Students and Its Impact on Self-Reported Confidence in Applying the Pharmacist’s Patient Care Process (PPCP)

(5-060) Reduction in Monthly Migraine Days in Patients Prescribed Galcanezumab versus Erenumab

(5-061) Fixed Rate vs. Variable Rate Continuous Insulin Infusion Regimens for the Treatment of Hypertriglyceridemia-Induced Pancreatitis

(5-062) Alvimopan Utilization Analysis: Opportunities for Pharmacist Intervention in a Large Community Hospital

(5-063) Retrospective Comparison of Vitamin B12 Intramuscular Injection Administration Prior to Pemetrexed in Non-Small Cell Lung Cancer and Malignant Mesothelioma

(5-064) Analysis of a Cystic Fibrosis-Specific Antibiogram Before and After FDA Approval of Elexacaftor/Tezacaftor/Ivacaftor (ETI)

(5-065) Evaluation of Hypertonic Saline Use Outside of the Intensive Care Unit

(5-066) Pharmacist Involvement in the Perioperative Management of Antirheumatic Medication in a Rheumatology Clinic

(5-067) Improving Community Pharmacist Climate Change Involvement in Montana

(5-068) Extended Use of Crotalidae Polyvalent Immune FAB (Ovine) Beyond 18-Hours

(5-069) Potential Benefit of Baclofen in Tapering Phenibut

(5-070) Medication Use Evaluation: Cholesterol Lowering Medication Optimization in Patients with Very High Risk ASCVD

(5-071) Evaluation of Albumin Use in Patients with Ascites Secondary to Cirrhosis

(5-072) Drug Use Evaluation: Trauma Dosing of Prophylactic Enoxaparin at St. Vincent Hospital

(5-073) Evaluation of Loop Diuretic Use in Hospitalized Adult Acute Decompensated Heart Failure (ADHF) Patients

(5-074) Treatment of Open Fractures: Review of Emergency Department Pharmacists' Impact on Antibiotic Administration

(5-075) Assessing Patient Controlled Analgesia Use in a Community Hospital Setting

(5-076) Evaluation of the Body-Weight Method in Predicting Lithium Concentrations in a Pediatric Population

(5-077) Evaluating High Dose Olanzapine in a Morbidly Obese Patient Using Therapeutic Drug Monitoring

(5-078) Combining Nirmatrelvir/Ritonavir with Nifedipine: A Cytochrome P450 3A4 Drug Interaction Case Report

(5-079) Development of a Formal Assessment to Guide Acute Agitation Medication Administration for Use on an Inpatient Adult Psychiatric Unit

(5-080) Cannabis Use Among Oncology Patients: Does the Patient Chart Documentation Always Report on Current Use of Cannabis Product?

(5-081) Sugammadex Medication Use Evaluation: A Retrospective Cohort Study of Recovery Following Perioperative Aminosteroid Neuromuscular Blockade

(5-082) Evaluation of Pharmacist-Led Intervention to Improve Access to Glucagon Emergency Devices

(5-083) Characterization and Evaluation of Medications Dispensed in Rural Villages Served During an International APPE in the Dominican Republic

(5-084) Inhaled Corticosteroid Use in Patients Admitted with Chronic Obstructive Pulmonary Disease Exacerbation Without Prior Maintenance Therapy at an Academic Medical Center

(5-085) Rituximab Induced Pulseless Electrical Activity

(5-086) Midodrine Utilization Evaluation for Hypotension in the Intensive Care Unit

(5-087) Evaluation of IV Fentanyl Infusion Dose in the Intensive Care Unit

(5-088) Erythropoietin Stimulating Agents: Drug Utilization Evaluation at Mount Auburn Hospital

(5-089) Pseudomonas Aeruginosa Bacteremia and Patient Outcome

(5-090) Syncopal Episode After Ingestion of Bowel Cleansing Preparation, Polyethylene Glycol 3350, for Colonoscopy Procedure

(5-091) Effect of Desmopressin Administration for Antiplatelet Reversal in Patients with Traumatic Intracranial Hemorrhage

(5-092) Can Financial Well-Being Be Improved in Low-Income Patients Without Increasing Salary? Findings from a Financial Education and Coaching Intervention

(5-093) Analysis of the Rate of Neonatal Intensive Care Unit Admissions When Non-Group B Streptococcus Specific Intrapartum Antibiotics Are Utilized

(5-094) Impact of a Student Pharmacist-Led Initiative to Improve Statin Use in Diabetes

(5-095) Analysis of Pre-Evaluation Use of Dementia Medications in Patients Undergoing Comprehensive Geriatric Assessment (CGA) for Cognitive Symptoms

(5-096) Cost Effectiveness Analysis of Pharmacist Intervention versus Usual Care in the Management of Osteoporosis

(5-097) Assessment of Current Phenytoin Dosing and Monitoring Patterns

(5-098) Assessment of the Implementation of a Heparin Bolus Nomogram for Percutaneous Coronary Intervention to Improve Time to Goal Activated Clotting Time: A Subgroup Analysis

(5-099) C1 Esterase Inhibitor for the Off-Label Treatment of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema

(5-100) Exploring the Effects of Cisplatin-Topotecan Combination Therapy on Cisplatin-Resistant Cervical Cancer HeLa Cells

(5-101) Predicting Substitutes for Doxorubicin Within the FAC and TAC Chemotherapeutic Regimens by Looking at Gene Regulation Similarities and Differences

(5-102) Assessing the Impact, in a Three-year Doctorate Pharmacy Program, of Additional End-of-day Quizzes in Student’s Attendance and Performance in Routine Quizzes Held the Following Day

(5-105) Exploring Nucleolin-G Protein Coupled Receptor Kinase 5 Interactions in Cisplatin Resistant Cervical Cancer Cells

(5-106) Utilizing Caenorhabditis Elegans as an Experimental Model to Predict Toxicity of Various Antidepressants

(5-107) Impact of Virtual Learning During the COVID-19 Pandemic on Pharmacy Students' Perceived Learning and Wellbeing

(5-108) Exploring the Effects of G Protein Coupled Receptor Kinase 2 and Beta Arrestin 2 on the Efficacy of the TAC Regimen

(5-110) Retrospective Medication Use Evaluation of Antiretrovirals for Human Immunodeficiency Virus During Hospitalization

(5-111) Exploring the Influence of Chlorpromazine Using Caenorhabditis Elegans as an Experimental Model

(5-112) Exploring Octopamine Activity Using Caenorhabitis Elegans as an Experimental Model

(5-113) Utilizing a Bioinformatic Approach for Identifying New G-Protein Coupled Receptor Kinase 5 Interacting Proteins - What Can We Learn from What Is Known?

(5-114) Investigating the Effects of Amlexanox in Combination with Cisplatin on Cervical Cancer Cells

(5-115) Exploring Adrenergic Receptor Antagonists Using Caenorhabditis Elegans as an Experimental Model

(5-116) Evaluation of Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitor Prescribing Patterns in Heart Failure Patients at Hospital Discharge

(5-117) Non-FDA Approved Nutraceuticals: An Evaluation of Structure and Function Memory Claims

(5-118) Retrospective Analysis of Clinical Outcomes Associated with Fluid Resuscitation in Sepsis or Septic Shock Based on Ideal Body Weight

(5-119) Naloxone Prescribing at Emergency Department Discharge After Opioid Overdose

(5-120) Retrospective Analysis of Adverse Effects Associated with Intravenous Insulin Infusions for Patients with Diabetic Ketoacidosis

(5-121) Evaluating Virologic Suppression Before, During, and After Pregnancy Among Women with Human Immunodeficiency Virus (HIV)

(5-122) Influencer Pharmaceutical Marketing: A Review of Food and Drug Administration (FDA) Warning and Untitled Letters

(5-123) Global Drug Shortages and Impact of COVID-19: Readiness Parameters and Best Practices

(5-124) Five Year Retrospective Analysis of Neurological Scales Used in Adult Clinical Trials for Major Depressive Disorder

(5-125) Wellness Program and Social Media Utilization by Pharmacy Residency Programs in the Tri-state Area and Comparisons to Medical Residency Programs

(5-126) Financial Impact Associated with Retrospective Implementation of Standardized Dose Rounding for Biologic and Cytotoxic Antineoplastic Agents

(5-127) Historical Analysis of Select Checkpoint Inhibitors in Clinical Trials and Guidelines for Non-Small Cell Lung Cancer

(5-128) Anti-Xa Level Monitoring for Enoxaparin in COVID-19 Patients

(5-129) Efficacy of Long-Acting Injectable Antipsychotics versus Oral Antipsychotics in Preventing Psychiatric Rehospitalizations

(5-130) Developing and Assessing an Interprofessional Pharmacy Student Peer-Led Curriculum for Pre-Health Undergraduate Students

(5-131) Analysis on the Use of Platelet Function Assays in Neurological Patients

(5-132) Non-Small Cell Lung Cancer (NSCLC) Systematic Literature Review of New Mechanisms of Action in Phase II and III Clinical Trials

(5-133) Designing a Protocol to Remotely Control Hypertension in Concurrent Disease

(5-134) Medication Use Evaluation of COVID-19 Vaccination in Patients Receiving Immunosuppressive Therapy

(5-135) Trends in Pediatric Immunizations in the United States Between 2010 and 2020

(5-136) Population Pharmacokinetic Model of Carbamazepine Using Inpatient Therapeutic Drug Monitoring

(5-137) Review of State Regulations for Pharmacists Prescribing of Hormonal Contraceptives

(5-138) Assessment of Biosimilar Policy Implementation at a Community Medical Center

(5-139) Current Trends in FDA Form 483 Observations for 503B Outsourcing Facilities Through COVID-19

(5-140) Evaluation of State Board of Pharmacy 503B Outsourcing Requirements Across All 50 States

(7-239) A Retrospective Evaluation of Specialty Clinical Pharmacist Services in Patients Starting TNF Inhibitors in Rheumatology and Dermatology Clinics

(5-142) Effects of Immune-Boosting Supplements on COVID-19 Symptoms

(5-143) Allergic versus Non-Allergic Angioedema: Using the Pharmacist Patient Care Process (PPCP) to Evaluate a Reaction to Angiotensin-Converting-Enzyme (ACE) Inhibitor Therapy in a Liver Transplant Patient

(5-144) Disruptors in the Retail Pharmacy Marketplace. Are They Effective?

(5-145) Assessing Clinical Studies Comparing Ruxolitinib to Current Standards of Care for the Treatment of Non-Segmental Vitiligo

(5-146) Evaluation of Adherence to Institutional Guidelines for the Use of Restricted Antibiotics

(5-147) Clinical Trial Variations of Current Investigational Drugs for Chemotherapy Induced Peripheral Neuropathy

(3-230) A System Wide Approach to Addressing Practical Challenges in Continuing Glucagon-Like Peptide-1 Receptor Agonists During Hospitalization

(5-149) Evaluation of High Alert and Look-alike, Sound-alike Medication Competency in the Outpatient Setting of a Community Hospital

(5-150) SGLT-2 Inhibitors Impact on Hospital Readmission Rates and Length of Stay in Heart Failure Patients

(5-151) An Analysis of COVID-Impacted Rutgers Pharmaceutical Industry Fellowship (RPIF) Interview Strategies and Perceptions: In-Person versus Virtual

(5-152) Evaluating Direct Oral Anticoagulant Appropriateness at a Community Hospital: A Retrospective Analysis

(5-153) Effect of Glucagon-Like Peptide-1 Receptor Agonists on Cardiovascular Outcomes: Systematic Literature Review

(5-154) Evaluation of Alcohol Withdrawal Syndrome Managed with Symptom-Triggered Benzodiazepines

(5-155) Critical Care: Pain and Agitation Management in Mechanically Ventilated Adults

(3-010) 2020 Heart Disease Deaths Compared to Medicare Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease Inhibitor (PCSK9i) Prescription Rates

(5-157) An Assessment of COVID-19 Clinical Trial Design Demographics and Outcome Measures Associated with Hydroxychloroquine and Ivermectin

(5-158) Elucidating the Mechanism of Inhibitory Activities of Riluzole in GRM1+ Melanoma Cells

(5-159) Analysis of FDA Warning Letters for Social Media Prescription Drug Promotion

(5-160) Analysis of Class of 2023 Fellowship Preferences

(5-161) Retrospective Evaluation of Short-Acting Injectable Antipsychotics for the Treatment of Agitation at a Community Hospital

(5-162) Retrospective Evaluation of Benzodiazepine Related Fall Events Reported at a Community Hospital

(5-163) Developmental Outcomes Associated with Fetal Exposure to Methadone and Buprenorphine: A Literature Review

(5-164) Effect of Blood Pressure Variability on Risk of Hemorrhagic Conversion in Patients That Received Alteplase for Acute Ischemic Stroke

(5-165) Effect of Augmented Renal Clearance on Vancomycin Trough Levels

(5-166) Monkeypox: A Disease Review, Current Treatment Strategies, and Ongoing Clinical Trials

(5-167) Evaluating the Timeliness of Administration, Cost, and Safety of Intravenous Push vs Intravenous Piggyback Levetiracetam: Single-Center, Retrospective Analysis